Universal Biosensors, Inc.

Equities

UBI

AU000000UBI2

Advanced Medical Equipment & Technology

Market Closed - Australian S.E. Other stock markets 09:31:07 2024-05-20 pm EDT			5-day change	1st Jan Change
0.13 ^AUD	-3.70%		-7.14%	-35.00%

May. 08	Universal Biosensors Raises AU$10 Million via Entitlement Offer	MT
May. 02	Universal Biosensors Narrows Q1 Loss as Revenue Rises; Shares Fall 3%	MT

Universal Biosensors, Inc. Announces Appointment of Promedeus s.r.o. as Its New Distribution Partner in Czech Republic and Slovak Republic

October 05, 2020 at 09:26 pm EDT

Universal Biosensors, Inc. announced the appointment of Promedeus s.r.o., as its new distribution partner in Czech Republic and Slovak Republic for Xprecia Stride products. The deal includes first year forecast sales from Promedeus of 30,000 Strips and 200 Xprecia Stride Analyzers. UBI has already received the first order for product which has recently been delivered.

Latest news about Universal Biosensors, Inc.

Universal Biosensors Raises AU$10 Million via Entitlement Offer	May. 07	MT
Universal Biosensors Narrows Q1 Loss as Revenue Rises; Shares Fall 3%	May. 02	MT
Universal Biosensors, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 01	CI
Universal Biosensors Opens AU$10 Million Rights Issue	Apr. 19	MT
Universal Biosensors to Raise AU$10 Million for Technology Development	Apr. 10	MT
H&G High Conviction Reports Flat Performance for March Quarter	Apr. 10	MT
Transcript : Universal Biosensors, Inc. - Shareholder/Analyst Call	Apr. 09
Australian Shares Rise as Central Bank Maintains Interest Rates	Mar. 19	MT
Universal Biosensors Secures US FDA Approval for Coagulation Analyzer Device; Shares Surge 78%	Mar. 18	MT
Transcript : Universal Biosensors, Inc., 2023 Earnings Call, Mar 07, 2024	Mar. 06
Universal Biosensors Narrows 2023 Loss on Absence of Impairment, Higher Revenue; Shares Down 6%	Feb. 29	MT
Universal Biosensors, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29	CI
Universal Biosensors Grows H2 2023 Sales by 55%	Jan. 31	MT
Transcript : Universal Biosensors, Inc., Q3 2023 Earnings Call, Nov 02, 2023	Nov. 01
Universal Biosensors, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	23-10-29	CI
Universal Biosensors' Coagulation Analysis Device Gets Approval in Europe	23-10-04	MT
Universal Biosensors Secures Marketing Approval, First Order for Coagulation Analyzer Device in India	23-08-31	MT
Universal Biosensors Secures First Major Tender to Supply Xprecia Prime in Italy	23-08-08	MT
Transcript : Universal Biosensors, Inc., Q2 2023 Earnings Call, Aug 08, 2023	23-08-07
Australian Shares Flat Ahead of Central Bank Policy Meeting	23-07-31	MT
Universal Biosensors Narrows Net Loss 74% in H1	23-07-30	MT
Universal Biosensors, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023	23-07-30	CI
Universal Biosensors, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-07-30	CI
Transcript : Universal Biosensors, Inc. - Shareholder/Analyst Call	23-05-21
Universal Biosensors Trims Q1 Loss on Lower Expenses, Absence of Intangible Assets Impairment	23-05-11	MT

Chart Universal Biosensors, Inc.

Duration

Period

More charts

Company Profile

Universal Biosensors, Inc. is a biosensor company. The Company is engaged in developing and commercializing a range of biosensors in oenology (wine industry), human health including oncology, coagulation, womenâs health and fertility, non-human and environmental testing using its platform technology and hand-held point-of-use devices. Its core technology consists of a disposable, multi-layer test strip, which incorporates an electrochemical sensing system using opposing electrodes that detect specific analytes in samples as small as a droplet. Its products include Sentia Wine Analyzer, Xprecia Prime Coagulation Analyzer, Hemostasis Reference Laboratory (HRL) and PETRACKR Veterinary Blood Glucose Monitoring System. HRL supports contract research organizations, central laboratories, early phase clinics, pharmaceutical/ biotechnology companies and academic researchers conducting clinical trials. HRL offers multiplex cytokine analysis on the MESO QuickPlex SQ 120MM technology platform.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-29 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
UNIVERSAL BIOSENSORS, INC.	-35.00%	20.86M
THERMO FISHER SCIENTIFIC	+10.66%	227B
DANAHER CORPORATION	+14.61%	198B
INTUITIVE SURGICAL, INC.	+18.53%	142B
BOSTON SCIENTIFIC CORPORATION	+31.08%	111B
SIEMENS HEALTHINEERS AG	+0.80%	64.16B
EDWARDS LIFESCIENCES CORPORATION	+18.66%	54.1B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+5.82%	51.41B
AGILENT TECHNOLOGIES, INC.	+9.95%	45.32B
GE HEALTHCARE TECHNOLOGIES INC.	+5.55%	37.32B

Other Advanced Medical Equipment & Technology